Upstream Bio (UPB) Net Margin (2023 - 2026)

Upstream Bio (UPB) recorded quarterly Net Margin of 3922.73% in Q1 2026, up 38.28% quarter-over-quarter from 6356.14% in Q4 2025, and up 89529.0% on a YoY basis from N/an in Q1 2025.

Upstream Bio (UPB) Net Margin (2023 - 2026) Analysis & Trends

Upstream Bio's Net Margin history runs 4 years deep, the most recent figure standing at 3922.73% for Q1 2026.

  • In Q1 2026, Net Margin rose 89529.0% year-over-year to 3922.73%; the TTM figure through Mar 2026 stood at 4718.06% (down 81323.0% YoY), while the FY2025 annual figure was 5026.03%, down 180262.0% from the prior year.
  • Net Margin was 3922.73% for Q1 2026 at Upstream Bio, up from 6356.14% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1006.92% in Q3 2023 to a low of 6356.14% in Q4 2025.
  • Historically, Net Margin has averaged 3789.5% across 4 years, with a median of 3835.69% in 2024.
  • The sharpest annual moves came in 2025 and 2026: Net Margin plunged 280149 bps in 2025, then surged 89529 bps in 2026.
  • A 4-year view of Net Margin shows it stood at 3329.78% in 2023, then decreased by 7 bps to 3554.65% in 2024, then sank by 79 bps to 6356.14% in 2025, then jumped by 38 bps to 3922.73% in 2026.
  • The last three Net Margin figures came in at 3922.73% (Q1 2026), 6356.14% (Q4 2025), and 4941.14% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Upstream Bio 339.03 Mn 339.03 Mn -3.94 Mn -3,922.73%

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,922.73%
Dec 31, 2025 -6,356.14%
Sep 30, 2025 -4,941.14%
Jun 30, 2025 -4,265.31%
Mar 31, 2025 -4,818.02%
Dec 31, 2024 -3,554.65%
Sep 30, 2024 -3,465.07%
Jun 30, 2024 -3,835.69%
Mar 31, 2024 -2,189.06%
Dec 31, 2023 -3,329.78%
Sep 30, 2023 -1,006.92%